ST6GAL1 and chronic obstructive pulmonary disease: Reduced ST6GAL1 and α-2-6 sialylation augment IL-6 expression/secretion in human bronchial epithelial cells (57). Plasma ST6GAL1 levels are associated with inflammation and exacerbation of COPD (57, 58).